Supplementary Material for: Intake of Proton Pump Inhibitors is Associated with a Shorter Time To First Treatment in early-stage Chronic Lymphocytic Leukemia.
Proton pump inhibitors (PPIs) are one of the most widely used drugs worldwide(1). The use of PPI has become a common practice, and are overprescribed for all patients with cancer including patients with hematological malignancies. In the current study, we aimed to explore retrospectively the effect...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|